Machine Learning is changing the methods of data analysis to automate historic model building. ML is using computers to find hidden insights without being told where to look.
Associate Professor and JP Morgan Faculty Fellow, University of Delaware
Computer scientist specializing in machine learning, compilers, high-performance computing, and cybersecurity. In particular, my research focuses on the application of machine learning techniques to problems in cybersecurity, high-performance computing, and compilation.
Chief Operating Officer, Insilico Medicine, Inc.
Dr. Qingsong Zhu is the Chief Operating Officer of Insilico Medicine, Inc. and is responsible for Insilico Medicine operations and drug development. He obtained his Ph.D. degree from Kansas State University in biochemistry. Dr. Zhu received his postdoctoral training at Johns Hopkins under the supervision of Dr. Nancy Davidson in breast cancer field. He has over 12 years of experience in genomics research and drug development. His latest entrepreneurial endeavors focused on improving the early diagnosis and personalized treatment of cancer and other age-related diseases.
Founder and CEO of VEEPIO
Jonathan has over 9 years’ experience in the financial technology sector prior to founding VEEPIO. As Managing Director at Singularity Technology Solutions, a financial technology software development company servicing the global capital markets, Jonathan specialized in implementing unique high frequency trading solutions for equities markets in the United States, Canada, Brazil, Argentina, London, and China. It was during this time that Jonathan developed his affinity for identifying advancements in technology and pairing them with emergent business models to generate platforms to serve the global social entrepreneur.